The warning noted that reports of adverse events following vaccination - particularly after the second dose - suggest increased risks of myocarditis, or inflammation of the heart muscle, and pericarditis, or inflammation of the tissue surrounding the heart [File: Virginia Mayo/AP]
26 Jun 2021
The US Food and Drug Administration (FDA) has added a warning about the risk of heart inflammation to fact sheets for Moderna and Pfizer-BioNTech COVID-19 vaccines.
The warning on Friday noted that reports of adverse events following vaccination – particularly after the second dose – suggest increased risks of myocarditis, or inflammation of the heart muscle, and pericarditis, or inflammation of the tissue surrounding the heart.
KEEP READING
Delta to account for 90 percent of EU coronavirus cases in August
Explainer: What is the Delta Plus coronavirus variant?
Coronavirus causes global rise in civil unrest: Report
Biden sees ‘brighter’ future and victory over coronavirus
The warning update follows an extensive review of information and discussion by the US Centers for Disease Control and Prevention (CDC’s) Advisory Committee on Immunization Practices meeting on Wednesday, the FDA said.
At end of the second week of June, more than 1,200 cases of myocarditis or pericarditis have been reported to the US Vaccine Adverse Event Reporting System.
The cases reportedly appear to be notably higher in males and in the week after the second vaccine dose.
There has been no comment from Pfizer and Moderna yet.
- Forums
- Political Debate
- Sydney in lockdown
The warning noted that reports of adverse events following...
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)